A carregar...
Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
BACKGROUND: Human epidermal growth factor receptor 2 (HER2)–positive breast cancer is highly aggressive and has higher risk of recurrence than HER2-negative cancer. With few treatment options available, new drug targets specific for HER2-positive breast cancer are needed. METHODS: We conducted a pha...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472971/ https://ncbi.nlm.nih.gov/pubmed/23042933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs396 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|